Stock GXH GREEN CROSS HEALTH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Green Cross Health Limited

Equities

GXH

NZBDOE0001S8

Drug Retailers

End-of-day quote New Zealand S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
0.86 NZD +3.61% Intraday chart for Green Cross Health Limited +14.67% -21.10%
May. 30 Green Cross Health Limited Announces Cash Distribution for the Full Year Ended March 31, 2024, Payment on June 21, 2024 CI
May. 30 Green Cross Health Net Profit Falls 19.7% in Fiscal 2024; Dividend Declared MT

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization 1 140.3 163.2 147.4 190.4 193.4 146.3
Enterprise Value (EV) 1 172.8 279.3 219.2 262.7 258 267.5
P/E ratio 8.73 x 12.1 x 8.81 x 7.78 x 4.29 x 12.5 x
Yield 7.14% 3.07% - 4.89% 5.19% 4.41%
Capitalization / Revenue 0.25 x 0.29 x 0.26 x 0.28 x 0.39 x 0.29 x
EV / Revenue 0.3 x 0.49 x 0.38 x 0.39 x 0.52 x 0.53 x
EV / EBITDA 5 x 6.9 x 5.5 x 4.43 x 6.54 x 7.13 x
EV / FCF 8.38 x 7.99 x 3.86 x 4.96 x 30.6 x 11 x
FCF Yield 11.9% 12.5% 25.9% 20.2% 3.26% 9.1%
Price to Book 1.13 x 1.31 x 1.04 x 1.19 x 1.01 x 0.95 x
Nbr of stocks (in thousands) 143,153 143,153 143,153 143,153 143,284 143,461
Reference price 2 0.9800 1.140 1.030 1.330 1.350 1.020
Announcement Date 5/29/19 7/24/20 5/28/21 5/27/22 5/30/23 5/30/24
1NZD in Million2NZD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales 1 567.2 568.5 570.4 670.3 493.6 503.9
EBITDA 1 34.54 40.48 39.86 59.28 39.43 37.49
EBIT 1 28.5 34.45 33.94 53.1 33.13 31.31
Operating Margin 5.02% 6.06% 5.95% 7.92% 6.71% 6.21%
Earnings before Tax (EBT) 1 27.43 23.64 28.93 48.04 27.1 22.42
Net income 1 16.1 13.49 16.75 24.56 45.23 11.76
Net margin 2.84% 2.37% 2.94% 3.66% 9.16% 2.33%
EPS 2 0.1122 0.0941 0.1169 0.1710 0.3146 0.0818
Free Cash Flow 1 20.63 34.95 56.74 53 8.421 24.34
FCF margin 3.64% 6.15% 9.95% 7.91% 1.71% 4.83%
FCF Conversion (EBITDA) 59.73% 86.35% 142.35% 89.42% 21.36% 64.92%
FCF Conversion (Net income) 128.08% 259.1% 338.71% 215.81% 18.62% 207.02%
Dividend per Share 2 0.0700 0.0350 - 0.0650 0.0700 0.0450
Announcement Date 5/29/19 7/24/20 5/28/21 5/27/22 5/30/23 5/30/24
1NZD in Million2NZD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 32.5 116 71.8 72.3 64.6 121
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.9401 x 2.87 x 1.8 x 1.219 x 1.638 x 3.232 x
Free Cash Flow 1 20.6 35 56.7 53 8.42 24.3
ROE (net income / shareholders' equity) 15.5% 12.6% 14.8% 20.9% 10.9% 8.59%
ROA (Net income/ Total Assets) 6.85% 6.71% 5.72% 8.58% 5.11% 4.99%
Assets 1 235.1 200.9 292.8 286.3 885.6 235.6
Book Value Per Share 2 0.8700 0.8700 0.9900 1.110 1.330 1.080
Cash Flow per Share 2 0.1200 0.2400 0.2600 0.3200 0.4000 0.1600
Capex 1 8.95 7.26 4.97 4.09 5.71 7.4
Capex / Sales 1.58% 1.28% 0.87% 0.61% 1.16% 1.47%
Announcement Date 5/29/19 7/24/20 5/28/21 5/27/22 5/30/23 5/30/24
1NZD in Million2NZD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Retail - Drugs without Grocery

1st Jan change Capi.
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-21.10% 75.63M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-12.38% 8.1B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+25.86% 1.25B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
-8.03% 360M
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+7.51% 285M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+8.89% 225M
PETMED EXPRESS, INC. Stock PetMed Express, Inc.
-48.15% 78.02M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+28.21% 62.96M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. GXH Stock
  4. Financials Green Cross Health Limited